Simvastatin (Biosim (20 mg)) is an HMG-CoA reductase inhibitor, also known as a "statin", used for lowering high cholesterol and triglycerides in certain patients with appropriate diet. It reduces the ...
JUVISYNC is indicated in patients for whom treatment with both sitagliptin and simvastatin is appropriate. Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in ...
FDA Approves New Labeling for VYTORIN to Include Data From SHARP Showing That VYTORIN Effectively Lowered LDL Cholesterol in These Patients, With Fewer Major Vascular Events in Patients Taking VYTORIN ...
The fact that 80 daily milligrams of simvastatin (brand name Zocor) can cause serious muscle damage has been known for years. So why did it take the Food and Drug Administration so long to tell ...
Guidelines for the use of lipid-lowering drugs vary by country and region; however, the NCEPATP III guidelines are currently more explicit and quantitative than those guiding therapy in other parts of ...
ORLANDO, Nov. 8 -- If patients taking simvastatin (Zocor) develop sleep disturbances, changing statins may be a good idea, researchers suggested here. Simvastatin modestly but significantly reduced ...
London, UK - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) is recommending that a combination tablet of fenofibrate ...
Exclusive: The UK medicines regulator is set to run into conflict with NICE guidance by advising there is ‘no significant benefit' in using doses of simvastatin over 20 mg. A spokesperson from the ...
The FDA rejected a new indication for Merck's Vytorin and Zetia (ezetimibe plus simvastatin and ezetimibe alone) in chronic kidney disease patients. As a consolation prize, however, the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback